Human BMPR-II Antibody, R&D Systems™

BMPR-II

Polyclonal

Unconjugated

Q13873

BMPR2

Mouse myeloma cell line NS0-derived recombinant human BMPR-II Ala26-Ile151 Accession # Q13873

100 μg

Primary

Detects human BMPR-II in direct ELISAs and Western blots. In direct ELISAs, less than 1% cross-reactivity with recombinant human (rh) BMPR-IA, recombinant mouse (rm) BMPR-IA, rhBMPR-IB, and rmBMPR-IB is observed.

Human

IgG

Western Blot, Flow Cytometry, Immunohistochemistry, CyTOF

LYOPH

Western Blot 0.1 ug/mL, Flow Cytometry 2.5 ug/10^6 cells, Immunohistochemistry 5-15 ug/mL, CyTOF-ready

BMP type II receptor, BMP type-2 receptor, BMPR2, BMPR-2, BMPR3, BMPRII, BMPR-IIprimary pulmonary hypertension 1, Bone morphogenetic protein receptor type II, bone morphogenetic protein receptor type-2, bone morphogenetic protein receptor, type II (serine/threonine kinase), BRK-3, EC 2.7.11, EC 2.7.11.30, FLJ41585, FLJ76945, PPH1BMR2, T-ALK, type II activin receptor-like kinase, type II receptor for bone morphogenetic protein-4

Goat

Affinity Purified

RUO

659

Reconstitute at 0.2 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.